Valuation: Cochlear Limited

Capitalization 16.8B 11.88B 9.98B 9.1B 8.69B 16.08B 1,076B 106B 42.09B 518B 44.56B 43.64B 1,832B P/E ratio 2026 *
42.5x
P/E ratio 2027 * 34.4x
Enterprise value 16.47B 11.65B 9.79B 8.92B 8.52B 15.77B 1,055B 104B 41.27B 508B 43.69B 42.78B 1,796B EV / Sales 2026 *
6.38x
EV / Sales 2027 * 5.74x
Free-Float
99.53%
Yield 2026 *
1.81%
Yield 2027 * 2.13%
1 day+1.49%
1 week-3.48%
Current month-4.53%
1 month-2.41%
3 months-9.81%
6 months-16.93%
Current year-1.44%
1 week 246.13
Extreme 246.13
266.67
1 month 246.13
Extreme 246.13
278.35
Current year 246.13
Extreme 246.13
278.35
1 year 246.13
Extreme 246.13
319.56
3 years 207.6
Extreme 207.6
350.31
5 years 178.54
Extreme 178.545
350.31
10 years 95.71
Extreme 95.71
350.31
Manager TitleAgeSince
Chief Executive Officer - 02/01/2018
Chief Tech/Sci/R&D Officer - 30/06/2019
Chief Tech/Sci/R&D Officer - 31/01/2023
Director TitleAgeSince
Chairman 58 20/08/2021
Director/Board Member - 13/11/2017
Director/Board Member 69 12/12/2016
Change 5d. change 1-year change 3-years change Capi.($)
+1.49%-3.48%-17.08%+19.74% 11.73B
+0.89%+7.11%-20.89%-21.97% 20.58B
-0.05%-2.06%-32.57%-12.14% 15.91B
-2.16%-4.39% - - 4.57B
+0.32%-1.27%-9.04%-6.02% 2.12B
-0.49%+1.39%-37.31%-52.96% 1.69B
-1.22%+9.04%+20.36%-44.10% 1.62B
-0.34%+0.17%+39.34%+69.94% 706M
+0.87%-1.42%+13.40% - 359M
+1.51%+1.30%-37.03%+96.31% 345M
Average +0.15%-0.56%-8.98%+6.10% 5.96B
Weighted average by Cap. +0.53%+0.62%-21.39%-9.23%

Financials

2026 *2027 *
Net sales 2.58B 1.82B 1.53B 1.4B 1.33B 2.47B 165B 16.23B 6.47B 79.62B 6.84B 6.7B 281B 2.86B 2.03B 1.7B 1.55B 1.48B 2.74B 183B 18.01B 7.18B 88.37B 7.6B 7.44B 312B
Net income 387M 274M 230M 210M 200M 371M 24.79B 2.43B 970M 11.94B 1.03B 1.01B 42.22B 489M 346M 291M 265M 253M 468M 31.32B 3.08B 1.23B 15.09B 1.3B 1.27B 53.33B
Net Debt -329M -233M -196M -178M -170M -315M -21.08B -2.07B -825M -10.15B -873M -855M -35.89B -356M -252M -212M -193M -184M -341M -22.82B -2.24B -893M -11B -945M -926M -38.86B
Logo Cochlear Limited
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services, and Acoustics. Cochlear Implants segment offers Cochlear implant systems. Services segment offers sound processor upgrades, accessories and other. Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Its Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Employees
5,500
Date Price Change Volume
10/02/26 256.90 $ +1.49% 87,651
09/02/26 253.12 $ +1.18% 107,415
06/02/26 250.17 $ -3.31% 184,907
05/02/26 258.74 $ -0.49% 105,166
04/02/26 260.01 $ -2.53% 136,931
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
256.90AUD
Average target price
301.76AUD
Spread / Average Target
+17.46%

Quarterly revenue - Rate of surprise